Healthcare | May 05, 2026
OBESITAS 2026 concludes with focus on India’s rising obesity burden
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
The trial targeted a patient population with high BMI and extensive skin involvement, averaging over 39 kg/m²
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
_Logo_256_384.png){kind=logo}
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
Cagrilintide represents a novel approach to obesity management
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Subscribe To Our Newsletter & Stay Updated
